These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2865794)

  • 21. [Correction of biochemical disorders in the lipid metabolism of atherosclerosis patients by using the antioxidant dibunol].
    Barsel' VA; Korochkin IM; Arkhipova GV; Sal'nikov MI; Matveeva SA
    Izv Akad Nauk SSSR Biol; 1988; (1):75-85. PubMed ID: 3351102
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
    Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid peroxide levels in chronic renal failure.
    Sharma AK; Arora M; Goyle A; Jain R; Gupta H; Gupta R
    J Assoc Physicians India; 1999 Mar; 47(3):296-7. PubMed ID: 10999124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
    Androne L; Gavan NA; Veresiu IA; Orasan R
    In Vivo; 2000; 14(2):327-30. PubMed ID: 10836205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum free thyroid hormone concentrations and indices in alcoholic liver cirrhosis, primary biliary cirrhosis and chronic active hepatitis.
    Liewendahl K; Helenius T; Tanner P; Salaspuro M
    Acta Endocrinol Suppl (Copenh); 1983; 251():21-6. PubMed ID: 6404084
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L; Dávid K; Nagy I; Stotz G; Kelemen JT
    Acta Physiol Hung; 1984; 64(3-4):461-70. PubMed ID: 6152370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipid peroxidation products in serum and its antioxidant activity as markers of human personality traits].
    Volchegorskiĭ IA; Khrebtova AIu
    Fiziol Cheloveka; 2002; 28(5):137-9. PubMed ID: 12397944
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment.
    Camps J; Marsillach J; Joven J
    Clin Chim Acta; 2007; 386(1-2):114-5. PubMed ID: 17850780
    [No Abstract]   [Full Text] [Related]  

  • 30. [Decrease of cholesterolemia and apolipoprotein B in chronic viral hepatitis C with massive steatosis].
    Carré D; Boucher E; Turlin B; Guyader D; Brissot P; Deugnier Y
    Gastroenterol Clin Biol; 1994; 18(10):899-900. PubMed ID: 7875402
    [No Abstract]   [Full Text] [Related]  

  • 31. [The effect of alpha-tocopherol on blood lipid peroxidation in patients with hepatic echinococcosis].
    Abidova SS; Ovchinnikov IV; Shamirzaev BI; Ishankulova GF
    Eksp Klin Farmakol; 1998; 61(3):41-2. PubMed ID: 9690076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Free radical, lipid peroxide and antioxidant in mitochondrial encephalomyopathy].
    Ihara Y; Hayabara T; Namba R; Nobukuni K; Mori A
    Rinsho Shinkeigaku; 1994 Jun; 34(6):593-5. PubMed ID: 7955720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum lipid peroxides in alcoholic patients].
    Rosnowska M; Langer D; Cendrowski W
    Psychiatr Pol; 1995; 29(4):539-46. PubMed ID: 7568526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of glycoconjugated biliary acids in the serum of chronic hepatitis patients and their correlation with liver function tests].
    Velo Bellver JL; Rabago Torre L; Fernández-Pacheco I; Castellanos D; Menchen PL; Clemente G; Senent C; López de la Riva M; Alcala Santaella R
    Rev Esp Enferm Apar Dig; 1983 Nov; 64(5):382-8. PubMed ID: 6658130
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficient antioxidant capacity against lipid peroxide levels in healthy elderly of Mexico City.
    Sánchez-Rodríguez MA; Retana-Ugalde R; Ruíz-Ramos M; Muñoz-Sánchez JL; Vargas-Guadarrama LA; Mendoza-Núñez VM
    Environ Res; 2005 Mar; 97(3):322-9. PubMed ID: 15589241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cholesterol and chronic hepatitis C.
    Maggi G; Bottelli R; Gola D; Perricone G; Posca M; Zavaglia C; Ideo G
    Ital J Gastroenterol; 1996; 28(8):436-40. PubMed ID: 9032585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].
    Bacq Y; Schillio Y; Brechot JF; De Muret A; Dubois F; Metman EH
    Gastroenterol Clin Biol; 1993; 17(5):364-9. PubMed ID: 8349072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of antioxidants and miscleron on destabilization of cell membranes during nephritis in children].
    Zhmurov VA; Krylov VI; Petrushina AD
    Vopr Med Khim; 1987; 33(1):40-3. PubMed ID: 3577056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The level of beta-endorphins in patients with chronic active hepatitis].
    Khvorostinka VN; Pasieshvili LM; Teslenko VG; D'iakonova IG; Biazrova VV
    Vrach Delo; 1991 May; (5):63-5. PubMed ID: 1866920
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)].
    Kiczka W; Juszczyk J; Adamek J
    Pol Tyg Lek; 1987 Feb; 42(7):192-6. PubMed ID: 3299322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.